Acomplia and its role in fighting obesity

Obesity among adults and children is a major problem worldwide. In fact, it is one of the leading causes of death the world over. In the United States alone, obesity is estimated to cause 365, 000 deaths a year making this preventable cause of death highly dangerous.

Although those who have large amounts of excess fat want to slim down for aesthetic purposes, the medical condition is treated not only because of body image issues but because it has adverse effects on a person’s health. Obesity can lead to lower life expectancy as well as cause a range of diseases. This includes heart diseases, breathing difficulties, type 2 diabetes, osteoarthritis and cancer.

Obesity is caused by eating too much and not engaging in a lot of physical activity such as sports but other people who are obese are overweight for genetic or medical reasons. Other contributing factors to obesity include insufficient sleep, pollutants that hinder lipid metabolism, medication that causes weight gain and assortative mating.

Another concern among dieticians and medical practitioners is the increasing reliance on fast food meals. Since people are almost always in a rush and barely have time to cook good, healthy food, they do not have a choice but to order food from their local fast food chains.  The link between eating fast food and obesity is definitely a relevant matter to take into consideration.

Those who suffer from obesity should not lose hope though because by following a healthy diet coupled with exercise will help you lose a lot of weight. Taking complementary pills such as Acomplia is also a good idea. The French pharmaceutical company Sanofi-Aventis created Acomplia, a medication that fights obesity. The weight loss drug is an approved drug in the United Kingdom and in several European countries.

Acomplia is the first among Cannabinoid-1 Receptor Blockers that has made it to the market. It is a very effective treatment for obesity because it blocks hunger signals in the brain.